Summary
The pharmacokinetics of coumarin (C) upon i.v. and p.o. administration and its metabolites 7-hydroxy-coumarin (7-HC) and 7-hydroxy-coumarin glucuronide (7-HCG) have been studied. Six healthy volunteers were involved in this investigation. Four of the volunteers participated in a crossover study. Coumarin was administered i.v. and p.o. in dose sizes of 0.25 mg/kg and 0.857 mg/kg, respectively. Coumarin is rapidly absorbed p.o., however the availability to systemic circulation is less than 4%. The rest of the dose appears quantitatively as 7-HC and 7-HCG in systemic circulation suggesting an extensive firstpass effect. Coumarin and 7-HCG are best fitted to an open two-compartment model, whereas 7-HC is best fitted to an open one-compartment model. The biological half-life of both C (0.80 vs. 1.02 h) and 7-HCG (1.47 vs. 1.15 h) was not significantly different for the two routes of administration. The large total clearance of C again suggests a first-pass effect; while that of 7-HCG, which is nearly exclusively eliminated into urine, indicates active tubular secretion of the glucuronide.
Similar content being viewed by others
References
Casley-Smith, J.R., Földi-Börcsök, E., Földi, M.: The electron microscopy of the effects of treatment with coumarin (Venalot) and by thoracic duct cannulation on thermal injuries. Brit. J. Exp. Pathol.53, 1–5 (1973)
Ehrhart, G., Rusching, H.: Arzneimittel, Vol. 1: Pharmacodynamica, p. 645–649. Weinheim: Verlag Chemie 1968
Fink, P.C., Kerekjarto von, B.: Zur enzymatischen Hydroxylierung von Coumarin, II. Die mikrosomalen Reaktionsprodukte bei verschiedenen Tierarten. Hoppe-Seylers Z. Physiol. Chem.345, 272–279 (1966)
Földi, M., Zoltán, Ö.T.: Über den Wirkungsmechanismus eines Melilotus-Präparates. Arzneim.-Forsch.15, 899–901 (1965)
Földi, M., Zoltán, Ö.T.: Experimentelle Thrombophlebitis und deren therapeutische Beeinflussung. Arzneim.-Forsch.15, 901–903 (1965)
Földi-Börcsök, E., Bedall, F.K., Rahlfs, V.W.: Die antiphlogistische und ödemhemmende Wirkung von Coumarin aus Melilotus officinalis. Arzneim.-Forsch.21, 2025–2030 (1971)
Johne, H.-O.: Experimental and clinical studies with the melilotus preparation esberiven. Ärztl. Forsch.14, 473–474 (1960)
Kaighen, M., Williams, R.T.: The metabolisms of 3−14 C-Coumarin. J. Med. Pharm. Chem.3, 25–43 (1961)
La Du, B.N., Mandel, H.G., Way, E.L.: Fundamentals of drug metabolism and drug disposition, p. 158–159. Baltimore: The Williams and Wilkins Co. 1971
Pabst, H.W., Klemm, H.: Experimentelle Untersuchungen zur Wirkung von Extrakten aus Melilotus officinalis. Med. Mschr.14, 589–591 (1960)
Piukovich, J., Zoltán, Ö.T., Traub, A., Földi, M.: Weitere Untersuchungen über die therapeutische Beeinflussung der experimentellen Thrombophlebitis. Arzneim.-Forsch.16, 94–97 (1966)
Ritschel, W.A., Hoffmann, K.A., Tan, H.S., Sanders, P.R.: Pharmacokinetics of coumarin upon i.v. administration in man. Arzneim.-Forsch.26, 1382–1387 (1976)
Ritschel, W.A., Tan, H.S., Hoffmann, K.A., Sanders, P.R., Schmucker, V.R.: Metabolism of coumarin upon i.v. administration in man. Symposium on Clinical Pharmacokinetics (W.A. Ritschel, Editor). Stuttgart: Gustav-Fischer Verlag 1977
Shilling, W.H., Crampton, R.F., Longland, R.C.: Metabolism of coumarin in man. Nature221, 664–665 (1969)
Shimamoto, K., Takaori, S.: Pharmakologische Untersuchungen mit einem Melilotus-Extrakt. Arzneim.-Forsch.15, 897–899 (1965)
Tan, H.S.I., Ritschel, W.A., and Sanders, P.R.: Determinations of courmarin and umbelliferone mixtures in whole blood by spectrophotofluorometry. J. Pharm. Sci.65, 30–33 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ritschel, W.A., Brady, M.E., Tan, H.S.I. et al. Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in man. Eur J Clin Pharmacol 12, 457–461 (1977). https://doi.org/10.1007/BF00561066
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561066